Europe Karyotyping Market Market - Industry Trends and Forecast to 2032
Europe karyotyping market is expected to reach USD 102,395.71 thousand by 2030 from USD 66,601.73 thousand in 2022, growing at a CAGR of 5.6% during the forecast period of 2023 to 2030.
Market SegmentationEurope Karyotyping Market, By Product (Instruments, Software & Services, and Consumables & Accessories), Type (Spectral Karyotyping, and Virtual Karyotyping), Application (Diagnosis, Personalized Medicines, Research, and Others), End User (Clinical & Research Laboratories, Hospitals, Pathology Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (Germany, France, U.K., Italy, Russia, Spain, Turkey, Belgium, Netherlands, Switzerland, Denmark, Norway, Sweden, Poland, Finland, and Rest of Europe) - Industry Trends and Forecast to 2030
Overview of Europe Karyotyping Market Dynamics
Driver
• Increasing cases of chromosomal abnormalities and adoption of sequencing testing
Restraint
• High cost of karyotyping testing
Opportunity
• Increasing technological advancements and innovation of new medical devices and instruments
Market Players
Some of the major market players operating in the Europe karyotyping market are:• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• Agilent Technologies, Inc.
• Sartorius AG
• Abbott
• Leica Biosystems Nussloch GmbH
• CytoTest Inc.
• PerkinElmer Inc.
• BioDot
• Bio-Rad Laboratories, Inc
• Creative Bioarray
• Applied Spectral Imaging
• West Medica Produktions- und Handels- GmbH
• Capricorn Scientific
• Empire Genomics, Inc
• Laboratory Imaging s.r.o.
• SciGene Corporation
• MetaSystems
• MICROPTIC